S2529Referred to Committee

A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-30
Introduced
1
Cosponsors
S
ⓘ
Type

Sponsor

Jon Husted
Jon Husted
Republican · OH · Senator
Votes with party: 75.2% (850 recorded votes)
Top industries funding sponsor:
  • Conservative Groups$35,115k

Full profile: /officials/H001104

Source: Congress.gov · FEC

Cosponsors (1)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2025-07-30

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

The proposal would create clearer rules and timelines for how pharmaceutical companies can request to switch medications from prescription-only to over-the-counter status, making the approval process more predictable and transparent. This would help drug makers understand exactly what steps they need to follow and what information the FDA requires when seeking to make a medicine available without a doctor's prescription. Patients could potentially gain faster access to certain medications they could buy directly, while companies would have more certainty about the process and timeline for getting approval.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.